Hengeler Mueller advises financing banks on Millipore takeover by Merck
02. March 2010
On 28 February 2010, Merck KGaA, a global pharmaceutical and chemical company, and Millipore Corporation, a leading life science company based in Massachusetts/USA, announced that they have entered into a definitive agreement under which Merck will acquire all outstanding shares of common stock of Millipore. The transaction value amounts to approximately EUR 5.3 bn (USD 7.2 bn). Bank of America Merrill Lynch, BNP Paribas and Commerzbank Aktiengesellschaft provide a term loan for purposes of financing the transaction.
Hengeler Mueller has been advising the financing banks. The Hengeler Mueller team included partner Thomas O. Cron and associate David Barst (both Frankfurt).
Hengeler Mueller has been working on this transaction in an integrated team together with the US law firm Davis Polk & Wardwell (partners: Peter Douglas and Bradley Smith).
